Aaron A. is a highly skilled Senior Scientist at Wildtype, specializing in process development focused on upstream operations to enhance salmon cellular yield, with a strong emphasis on next generation animal-component free processes. Prior experience includes significant roles at Sangamo Therapeutics, Inc., where Aaron A. served as CMC Upstream Process Lead for a Fabry clinical drug candidate, leading successful tech transfers and process scaling efforts. Additional expertise encompasses upstream process development for AAV production at the scientist II level, and bioreactor work during a postdoctoral fellowship at AstraZeneca, contributing to advancements in cell culture and metabolic analysis. Aaron A. holds a Ph.D. in Chemical Engineering, along with graduate and undergraduate degrees in Chemical Engineering and Chemistry from the University of Colorado Boulder and the University of Maryland, respectively.
This person is not in any teams
This person is not in any offices